Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
For this to occur, a marker that predicts patient response to the drug is essential
"For some people, having a pill option can fit better into their daily routines
Ofev (nintedanib) Disease area(s): Respiratory Manufacturer(s): Boehringer Ingelheim 2024 Sales (USD): $4.07 billion Why it sold so well: In 2024, Boehringer Ingelheims Ofev achieved significant commercial success, with global sales reaching 3.77 billion ($4.07 billion), marking a 7.3% increase at constant exchange rates compared to the previous year
Take our health questionnaire to find the Solal products suggested for you based on your answers
US$ 20.65
US$ 27.16
US$ 22.35
US$ 26.43
US$ 29.78
US$ 20.16
US$ 27.94
US$ 23.60
US$ 25.37
